As demonstrated in this study and schematically illustrated in Figure 7b, treatment of breast cancer cells with a pan-HDACi like TSA induces recruitment of eIF6 to 60S subunits along with acetylation of RPL24 at K27, likely impairing 40S-60S joining. Here, EIF6 is linked to breast carcinoma.